Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–12 of 12 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT01805076
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +10 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
- Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
- Enloe Medical Center Chico, California, United States
NCT01818063
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +12 more
- Locations
-
- Walter Reed National Military Medical Center Bethesda, Maryland, United States
- Thomas Jefferson University Philadelphia, Pennsylvania, United States
- Reading Hospital Reading, Pennsylvania, United States
NCT00577122
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +7 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California, San Francisco Comprehensive Cancer Center San Francisco, California, United States
- Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
NCT01037790
- Conditions
- Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Adult Central Nervous System Germ Cell Tumor, +74 more
- Locations
-
- Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States
Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer
NCT00733408
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +10 more
- Locations
-
- Anchorage Oncology Centre Anchorage, Alaska, United States
- Katmai Oncology Group Anchorage, Alaska, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Yuma Cancer Center Yuma, Arizona, United States
NCT00194779
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +12 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01104259
- Conditions
- Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +14 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00003199
- Conditions
- Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +13 more
- Locations
-
- Fred Hutchinson Cancer Research Center/Puget Sound Oncology Consortium Seattle, Washington, United States
NCT00516243
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +9 more
- Locations
-
- Columbia University Medical Center New York, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Baylor College of Medicine Houston, Texas, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT00559507
- Conditions
- Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +11 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Adult Primary Liver Cancer, +182 more
- Locations
-
- University of Virginia Charlottesville, Virginia, United States
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer
NCT02315196
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +13 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States